Google AI Tool Identifies a Tumor’s Mutations From an Image

Google AI Tool Identifies a Tumor’s Mutations From an Image

  • September 17, 2018
Table of Contents

Google AI Tool Identifies a Tumor’s Mutations From an Image

The algorithm can distinguish between different kinds of lung cancer, and could speed up a patient’s diagnosis by weeks. The image shows the process by which an AI tool analyzes a slice of cancerous tissue to create a map that tells apart two lung cancer types which require different treatments, with squamous cell carcinoma in red, lung squamous cell carcinoma in blue, and normal lung tissue in gray. For decades, doctors have relied on the well-trained eyes of human pathologists to give their patients a cancer diagnosis.

Now, researchers are teaching machines to do that time-intensive work in as little as a few seconds. In new research published today in Nature Medicine, scientists at New York University re-trained an off-the-shelf Google deep learning algorithm to distinguish between two of the most common types of lung cancers with 97 percent accuracy. This type of AI—the same tech that identifies faces, animals, and objects in pictures uploaded to Google’s online services—has proven adept at diagnosing disease before, including diabetic blindness and heart conditions.

But NYU’s neural network learned how to do something no pathologist has ever done: identify the genetic mutations teeming inside each tumor from just a picture.

Source: wired.com

Share :
comments powered by Disqus

Related Posts

New anti-cancer drugs put cancers to sleep—permanently

New anti-cancer drugs put cancers to sleep—permanently

In a world first, Melbourne scientists have discovered a new type of anti-cancer drug that can put cancer cells into a permanent sleep, without the harmful side-effects caused by conventional cancer therapies. Published today in the journal Nature, the research reveals the first class of anti-cancer drugs that work by putting the cancer cell to sleep – arresting tumour growth and spread without damaging the cells’ DNA. The new class of drugs could provide an exciting alternative for people with cancer, and has already shown great promise in halting cancer progression in models of blood and liver cancers, as well as in delaying cancer relapse.

Read More
‘Ground-breaking’ diabetes insulin drug trialled in Cardiff

‘Ground-breaking’ diabetes insulin drug trialled in Cardiff

A ‘ground-breaking’ drug that helps people with diabetes re-grow insulin-making cells has been developed. About 19,000 people live with Type 1 of the condition in Wales and 90% have less than 5% of these cells left. This means they have to inject insulin

Read More